These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14081269)

  • 21. Discussion.
    J Am Coll Surg; 2017 Apr; 224(4):582-584. PubMed ID: 28343501
    [No Abstract]   [Full Text] [Related]  

  • 22. [Estimation upon euglobulin clot lysis time, fibrin plate methods, and their clinical value (author's transl)].
    Fujita S
    Rinsho Byori; 1974 Aug; 22(8):539-44. PubMed ID: 4473623
    [No Abstract]   [Full Text] [Related]  

  • 23. A study of the possible correlation of euglobulin lysis time and dilute blood clot lysis time in the determination of fibrinolytic activity.
    Menon IS
    Lab Pract; 1968 Mar; 17(3):334-5. PubMed ID: 4171025
    [No Abstract]   [Full Text] [Related]  

  • 24. Teaching an old dog new tricks?
    Gatt A; Vella K
    Br J Haematol; 2019 Nov; 187(4):416-417. PubMed ID: 31364157
    [No Abstract]   [Full Text] [Related]  

  • 25. Persistent Fibrinolysis Shutdown: In reply to Tonglet and colleagues.
    Meizoso JP; Proctor KG
    J Am Coll Surg; 2017 Dec; 225(6):832-833. PubMed ID: 29173340
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinolysis Shutdown in Severely Injured Trauma Patients: A New World to Explore.
    Tonglet ML; D'Orio V; Ghuysen A; Poplavsky JL
    J Am Coll Surg; 2017 Dec; 225(6):831-832. PubMed ID: 29173339
    [No Abstract]   [Full Text] [Related]  

  • 27. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.
    Kang Y; Lewis JH; Navalgund A; Russell MW; Bontempo FA; Niren LS; Starzl TE
    Anesthesiology; 1987 Jun; 66(6):766-73. PubMed ID: 3296855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered Fibrin Clot Properties in Patients With Cerebral Venous Sinus Thrombosis: Association With the Risk of Recurrence.
    Siudut J; Świat M; Undas A
    Stroke; 2015 Sep; 46(9):2665-8. PubMed ID: 26173730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M; Blinc A
    Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis.
    Wu JH; Siddiqui K; Diamond SL
    Thromb Haemost; 1994 Jul; 72(1):105-12. PubMed ID: 7974357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preface: Altered Fibrinolysis-Clinical Impact and Diagnostic Challenges.
    Larsen JB; Lisman T; Hvas AM
    Semin Thromb Hemost; 2021 Jul; 47(5):477-479. PubMed ID: 34192793
    [No Abstract]   [Full Text] [Related]  

  • 32. Impaired plasma clot lysis and its determinants in patients with obstructive sleep apnea syndrome.
    Borratynska A; Stopyra-Pach K; Fil K; Undas A
    Blood Coagul Fibrinolysis; 2016 Dec; 27(8):892-898. PubMed ID: 27167858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinolysis Shutdown in COVID-19-Infected Patients Can Result from Iron-Induced Stabilization of Fibril Clots.
    Sukhomlin T
    J Am Coll Surg; 2020 Nov; 231(5):607-608. PubMed ID: 32972832
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of remote ischaemic conditioning on coagulation and fibrinolysis.
    Kristiansen J; Grove EL; Rise N; Neergaard-Petersen S; Würtz M; Kristensen SD; Hvas AM
    Thromb Res; 2016 May; 141():129-35. PubMed ID: 27018926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bidirectional functions of thrombin on fibrinolysis: Evidence of thrombin-dependent enhancement of fibrinolysis provided by spontaneous plasma clot lysis.
    Tomczyk M; Suzuki Y; Sano H; Brzoska T; Tanaka H; Urano T
    Thromb Res; 2016 Jul; 143():28-33. PubMed ID: 27179129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An evaluation of euglobulin clot lysis time (ELT) measurement with the time saving recorder (author's transl)].
    Amemiya Y; Amaki I; Ariga T; Sawai H; Oshiba S
    Rinsho Ketsueki; 1973 Oct; 14(10):1008-17. PubMed ID: 4796985
    [No Abstract]   [Full Text] [Related]  

  • 37. Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives.
    Krzek M; Ciesla-Dul M; Zabczyk M; Undas A
    Thromb Res; 2012 Oct; 130(4):e216-21. PubMed ID: 22940058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
    Blanié A; Bellamy L; Rhayem Y; Flaujac C; Samama CM; Fontenay M; Rosencher N
    Thromb Res; 2013 Jan; 131(1):e6-e11. PubMed ID: 23195143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.